Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Hair loss linked to higher heart disease risk in both men and women.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.